The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

Under the auspices of His Highness Sayyid Marwan bin Turki al Said, Governor of Dhofar, Oman Design Week (ODW) officially began at the Al Irfan Boulevard Garden in the Oman Convention and Exhibition ...

NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...

The economies of Oman and the Gulf Cooperation Council (GCC) are undergoing profound transformations as they contend with fluctuating oil revenues, climate change, and shifting global economic ...